cures Doctors Foster and Smith Dental Cleans Pad Generic Name: chlorhexidine gluconate cloth Dosage Form: FOR ANIMAL USE ONLY Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Drs. Foster and Smith Dental Cleans Pads help promote healthy teeth and gums through regular use. Also reduce bad breath and plaque build up. For Dogs and Cats. DIRECTIONS FOR USE Hold animal's head steady with one hand and gently wipe teeth and gums with pad. Use additional pads as needed until entire mouth has been cleaned. ACTIVE INGREDIENT 0.1% Chlorhexidine Gluconate OTHER INGREDIENTS Water, Glycerin, Polysorbate 80, Peppermint Flavor, carmine Color. Item# 8523 For Questions or to Reorder: 1-800-562-7169 or www.drsfostersmith.com Doctors Foster and smith DentalClens Pads Cleans teeth and gums Freshens breath 90 pads Formulated by our veterinarians DOCTORS FOSTER AND SMITH chlorhexidine gluconate cloth Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:65713-902 Route of Administration DENTAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Chlorhexidine Gluconate (CHLORHEXIDINE) Chlorhexidine Gluconate 0.55 g in 103.6 g Inactive Ingredients Ingredient Name Strength WATER GLYCERIN POLYSORBATE 80 Product Characteristics Color brown (carmine color) Score Shape Size Flavor PEPPERMINT (peppermint flavor) Imprint Code Contains Packaging # Item Code Package Description 1 NDC:65713-902-05 103.6 g in 1 JAR Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/23/2010 Labeler - Doctors Foster and Smith (122135148) Registrant - United Pet Group (931135730) Establishment Name Address ID/FEI Operations JUNGLE LABORATORIES CORPORATION 032615270 manufacture Revised: 02/2010 Doctors Foster and Smith FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More now and again
accepted Doctors Foster and Smith Dental Cleans Pad understand that
EmoticonEmoticon